LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006445.3:c.6912C>T
PRPF8
· NP_006436.3:p.(Phe2304=)
· NM_006445.3
GRCh37: chr17:1554192 G>A
·
GRCh38: chr17:1650898 G>A
Gene:
PRPF8
Transcript:
NM_006445.3
Final call
VUS
PM2 moderate
Variant details
Gene
PRPF8
Transcript
NM_006445.3
Protein
NP_006436.3:p.(Phe2304=)
gnomAD AF
4.956439095895945e-06 (v4.1)
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 moderate is supported by the gnomAD v4.1 allele frequency of 4.95644e-06, below the generic threshold.
Final determination:
Under generic ACMG/AMP 2015 rules, one moderate criterion alone satisfies no pathogenic, likely pathogenic, benign, or likely benign combination, resulting in VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | N/A | Not applicable: PS1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no proband-level de novo observation or confirmed maternity and paternity is documented for PRPF8 c.6912C>T. |
|
| PS3 | Not assessed | Not assessed: no functional assay tested the exact c.6912C>T synonymous variant, while available assays studied different PRPF8 substitutions. |
PMID:17934474
PMID:17317632
PMID:17473007
|
| PS4 | Not met | Not met: reviewed cohorts did not report PRPF8 c.6912C>T, so no affected-versus-control counts, odds ratio, or confidence interval support PS4. |
PMID:11468273
PMID:16799052
PMID:23950152
PMID:28076437
PMID:33576794
gnomad_v4
|
| PM1 | N/A | Not applicable: PM1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PM2 | Met | Met at Moderate: gnomAD v4.1 AF is 4.95644e-06, below the 0.0001 extremely-low-frequency PM2 cutoff. |
gnomad_v4
|
| PM3 | N/A | Not applicable: PRPF8 retinitis pigmentosa is described as autosomal dominant, whereas PM3 is restricted to recessive disorders. |
PMID:11468273
PMID:23950152
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | Not applicable: PM5 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no affected proband with PRPF8 c.6912C>T and assumed de novo status is documented, regardless of parental confirmation. |
|
| PP1 | Not assessed | Not assessed: zero affected relatives or informative meioses are documented for segregation of PRPF8 c.6912C>T. |
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| PP3 | Not met | Not met: SpliceAI max delta 0.141 is below the >=0.2 PP3 supporting threshold. |
spliceai
|
| PP4 | Not assessed | Not assessed: the supplied evidence lacks patient phenotype and family-history details needed to judge whether the presentation is highly specific for a single etiology. |
|
| PP5 | Not met | Not met: the exact variant is absent from ClinVar, with zero submissions and zero expert-panel pathogenic or likely-pathogenic classifications. |
|
| BA1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 4.43e-06, far below the 0.05 BA1 threshold. |
gnomad_v4
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 4.43e-06, below the generic 0.01 BS1 threshold. |
gnomad_v4
|
| BS2 | Not assessed | Not assessed: gnomAD shows two heterozygous alleles but does not establish healthy-adult status or early full penetrance. |
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no well-established assay demonstrated normal protein function or splicing for the exact c.6912C>T synonymous variant. |
PMID:17934474
PMID:17317632
PMID:17473007
|
| BS4 | Not assessed | Not assessed: no affected relative tested negative for PRPF8 c.6912C>T is documented. |
|
| BP1 | N/A | Not applicable: BP1 requires a missense variant, and this is a synonymous variant. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no parental/offspring phase data or pathogenic partner establishes the queried variant in trans or cis. |
PMID:11468273
PMID:23950152
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a synonymous variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: SpliceAI max delta 0.141 exceeds the <=0.1 BP4 no-impact threshold. |
spliceai
|
| BP5 | Not assessed | Not assessed: no case carrying the exact variant with an independently established alternate molecular basis for disease is documented. |
|
| BP6 | Not met | Not met: the exact variant is absent from ClinVar, with zero submissions and zero expert-panel benign or likely-benign classifications. |
|
| BP7 | Not met | Not met: SpliceAI max delta 0.141 is above the supplied <=0.1 no-impact cutoff. |
spliceai
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.